ArticleDermatology and therapy2023

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.

Alexa B Kimball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.